Dudediligence.

Fennec Pharmaceuticals Inc

FENCNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,214,709

16 notices · 224,479 sh

Oct 2025 to Oct 2026

Reported ·

$10.8M

16 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

10 of 16 reported sales carry the 10b5-1 box. Together they are 3.99% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-15: MARCO BRUGHERA, Form 1442026-09-01: ROSTISLAV RAYKOV, Form 1442026-08-31: PIERRE S SAYAD, Form 1442026-08-27: ROBERT ANDRADE, Form 1442026-08-03: ROSTISLAV RAYKOV, Form 1442026-07-01: ROSTISLAV RAYKOV, Form 1442026-06-01: ROSTISLAV RAYKOV, Form 1442026-05-11: CHRIS A RALLIS, Form 1442026-05-01: ROSTISLAV RAYKOV, Form 1442026-04-01: ROSTISLAV RAYKOV, Form 1442026-03-02: ROSTISLAV RAYKOV, Form 1442026-02-02: ROSTISLAV RAYKOV, Form 1442026-01-02: ROSTISLAV RAYKOV, Form 1442025-12-05: ROSTISLAV RAYKOV, Form 1442025-11-05: ROSTISLAV RAYKOV, Form 1442025-10-10: CHRIS A RALLIS, Form 1442025-10-08: Southpoint Capital Advisors LP, sold2025-10-10: RALLIS CHRIS A, sold2025-11-05: Raykov Rosty, sold2025-11-14: Southpoint Capital Advisors LP, sold2025-11-18: Southpoint Capital Advisors LP, sold2025-12-05: Raykov Rosty, sold2025-12-24: Southpoint Capital Advisors LP, sold2026-01-02: Raykov Rosty, sold2026-02-02: Raykov Rosty, sold2026-03-02: Raykov Rosty, sold2026-04-01: Raykov Rosty, sold2026-05-01: Raykov Rosty, sold2026-05-11: RALLIS CHRIS A, sold2026-06-01: Raykov Rosty, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-15MARCO BRUGHERA, Director$160,070
15,545 shplan 2026-06-16Form 4s on file end Jun 23144 ↗
2026-09-01ROSTISLAV RAYKOV, Former Director$121,177
10,000 shplan 2025-09-19Form 4s on file end Jun 23144 ↗
2026-08-31PIERRE S SAYAD, Chief Medical Officer$146,170
12,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-27ROBERT ANDRADE, CHIEF FINANCIAL OFFICER$883,898
75,000 shplan 2026-05-22Form 4s on file end Jun 23144 ↗
2026-08-03ROSTISLAV RAYKOV, Former Director$95,835
10,000 shplan 2025-09-19Form 4s on file end Jun 23144 ↗
2026-07-01ROSTISLAV RAYKOV, Director$99,987
9,599 shplan 2025-09-19Form 4s on file end Jun 23144 ↗
2026-06-01ROSTISLAV RAYKOV, Director$93,814
9,747 shplan 2025-09-19144 ↗
Form 4, 2026-06-02: sold 9,747 at $9.62 Form 4 ↗
2026-05-11CHRIS A RALLIS, Director$58,833
8,346 shplan 2025-05-19144 ↗
Form 4, 2026-05-12: sold 8,346 at $7.04 Form 4 ↗
2026-05-01ROSTISLAV RAYKOV, Director$69,762
10,781 shplan 2025-09-19144 ↗
Form 4, 2026-05-01: sold 10,781 at $6.47 Form 4 ↗
2026-04-01ROSTISLAV RAYKOV, Director$69,073
10,946 shplan 2025-09-19144 ↗
Form 4, 2026-04-02: sold 10,946 at $6.31 Form 4 ↗
2026-03-02ROSTISLAV RAYKOV, Director$84,354
10,079 shplan 2025-09-19144 ↗
Form 4, 2026-03-03: sold 10,079 at $8.36 Form 4 ↗
2026-02-02ROSTISLAV RAYKOV, Director$80,339
10,349 shplan 2025-09-19144 ↗
Form 4, 2026-02-02: sold 10,349 at $7.76 Form 4 ↗
2026-01-02ROSTISLAV RAYKOV, Director$78,471
10,312 shplan 2025-09-19144 ↗
Form 4, 2026-01-05: sold 10,312 at $7.60 Form 4 ↗
2025-12-05ROSTISLAV RAYKOV, Director$75,444
10,000 shplan 2024-08-23144 ↗
Form 4, 2025-12-05: sold 10,000 at $7.54 Form 4 ↗
2025-11-05ROSTISLAV RAYKOV, Director$81,082
10,000 shplan 2024-08-23144 ↗
Form 4, 2025-11-06: sold 10,000 at $8.10 Form 4 ↗
2025-10-10CHRIS A RALLIS, Director$16,401
1,775 shplan 2025-05-19144 ↗
Form 4, 2025-10-14: sold 1,775 at $9.24 Form 4 ↗